Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
The use of erdafitinib was associated with an objective tumor response in 40% of previously treated patients who had locally advanced and unresectable or metastatic urothelial c...
Publications
2 shownFrequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 2,505
- Institution
- The University of Texas MD Anderson Cancer Center
External Links
Identifiers
- ORCID
- 0000-0002-6328-9599
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.